FI973049A0 - Corticosteroid-containing liposomes - Google Patents

Corticosteroid-containing liposomes

Info

Publication number
FI973049A0
FI973049A0 FI973049A FI973049A FI973049A0 FI 973049 A0 FI973049 A0 FI 973049A0 FI 973049 A FI973049 A FI 973049A FI 973049 A FI973049 A FI 973049A FI 973049 A0 FI973049 A0 FI 973049A0
Authority
FI
Finland
Prior art keywords
corticosteroid
containing liposomes
liposomes
Prior art date
Application number
FI973049A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI973049A (en
Inventor
Peter William Taylor
Janet Catherine Maas
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI973049A publication Critical patent/FI973049A/en
Publication of FI973049A0 publication Critical patent/FI973049A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI973049A 1995-01-24 1997-07-18 Corticosteroid-containing liposomes FI973049A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9501286.0A GB9501286D0 (en) 1995-01-24 1995-01-24 Pharmaceutical compositions and preparations thereof
PCT/GB1996/000083 WO1996022764A1 (en) 1995-01-24 1996-01-17 Liposomes containing a corticosteroid

Publications (2)

Publication Number Publication Date
FI973049A FI973049A (en) 1997-07-18
FI973049A0 true FI973049A0 (en) 1997-07-18

Family

ID=10768424

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973049A FI973049A0 (en) 1995-01-24 1997-07-18 Corticosteroid-containing liposomes

Country Status (10)

Country Link
EP (1) EP0859598A1 (en)
JP (1) JPH10512876A (en)
CN (1) CN1169115A (en)
AU (1) AU4396196A (en)
CA (1) CA2210482A1 (en)
CZ (1) CZ234297A3 (en)
FI (1) FI973049A0 (en)
GB (1) GB9501286D0 (en)
NO (1) NO973401L (en)
WO (1) WO1996022764A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59805997D1 (en) 1997-08-18 2002-11-21 Max Planck Gesellschaft PHOSPHOLIPID ANALOG CONNECTIONS
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
EP1133301A1 (en) * 1998-11-26 2001-09-19 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
EP1180017B8 (en) 1999-05-27 2010-05-19 Euro-Celtique S.A. Preparations with povidon iodine for wound treatment
AU2001241045A1 (en) * 2000-03-09 2001-09-17 Kissei Pharmaceutical Co. Ltd. Preventive or therapeutic drugs for eye diseases
GB0029562D0 (en) 2000-12-04 2001-01-17 Novartis Ag Organic compounds
DE10255285A1 (en) * 2002-11-26 2004-06-03 Mcs Micro Carrier Systems Gmbh Self-forming phospholipid gels
JP5193870B2 (en) * 2006-09-05 2013-05-08 キユーピー株式会社 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifier

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607028A (en) * 1983-08-18 1986-08-19 Ciba-Geigy Corporation Novel carboxylic acid esters
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
SE8603812D0 (en) * 1986-09-12 1986-09-12 Draco Ab ADMINISTRATION OF LIPOSOMES TO MAMMALS
US5043165A (en) * 1988-12-14 1991-08-27 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs

Also Published As

Publication number Publication date
AU4396196A (en) 1996-08-14
MX9705592A (en) 1997-11-29
NO973401D0 (en) 1997-07-23
GB9501286D0 (en) 1995-03-15
CN1169115A (en) 1997-12-31
FI973049A (en) 1997-07-18
WO1996022764A1 (en) 1996-08-01
CA2210482A1 (en) 1996-08-01
CZ234297A3 (en) 1997-10-15
EP0859598A1 (en) 1998-08-26
NO973401L (en) 1997-07-23
JPH10512876A (en) 1998-12-08

Similar Documents

Publication Publication Date Title
DE59602881D1 (en) SET POINTS
DE69608259D1 (en) ASSOCIATION
ATA135896A (en) SKIBOB
FI973049A (en) Corticosteroid-containing liposomes
ATE198470T1 (en) ALKENYL-BENZOYLGUANIDINE
ATE240972T1 (en) CYCLOPEPTOLIDES
FI950335A (en) Help agents
ATA119896A (en) Scheibenmähwerk
DE59600405D1 (en) HELP
ITVR950002A0 (en) ANTI-TRIP DRAWN
BR7500363U (en) Form
KR970028193U (en) Improvement
KR960038266U (en) Improvement
KR970034211U (en) Gloverbox Structure
KR970041857U (en) Bootband structure
NO952169D0 (en) Structure
KR970030874U (en) Ceftinob structure
KR960027269U (en) Banzadori structure
ITMI950827A0 (en) STRUCTURE
BR7500825U (en) Chutegol
BR7501426U (en) Búlica
BR7500838U (en) Broomwater
BR7501298U (en) Torre-audio-visual
BR7500809U (en) Tele-business
BR7500703U (en) Rodopratic